COVID-19

Top news of the week from Pharmacy Times.

Many manufacturers are making headway in the race for a COVID-19 vaccine, with about 5 players in phase 3 trials.

Hospitalized patients with COVID-19 treated with enoxaparin were found to have lower rates of thrombosis, kidney injury, and mortality than patients treated with unfractionated heparin.

Age has been connected to symptom severity and mortality in COVID-19, however, it does not affect susceptibility to infection with the virus.

Although researchers still hope to learn what protection immunoglobulin G antibodies offer against re-infection, this study could have broad implications in the development of a COVID-19 vaccine.

One in 4 adults reported a change in alcohol use almost immediately after stay-at-home orders were issued during the coronavirus disease 2019 pandemic.

The combination of isolating potentially sick patients in their car and conducting the test in a ventilated setting minimizes COVID-19 transmission to the rest of the population.

The physical and emotional stress of a COVID-19 diagnosis might be the triggering factor for the development of herpes zoster ophthalmicus.

Investigators found a link between the sleep quality of mother and child related to the COVID-19 pandemic.

Higher rates of mental health symptoms were found among younger respondents, those who identified themselves as female, and those who reported having a pre-existing mental health condition.

Data from all 50 states and the District of Columbia showed a gradual, steady decline in viral transmission rates during the 8 weeks immediately preceding relaxation of physical distancing rules.

Given the collision of COVID-19 and flu season, receiving the flu vaccine may hold additional benefits by reducing symptoms that may be confused with those of the novel coronavirus.

Those hospitalized for COVID-19 are, on average, younger and healthier than hospitalized flu patients.

By using a positive outlook on these circumstances, pharmacy students can learn many lessons that will set them up for success in the future.

This week on Pharmacy Times, there are a number of hot topics that we will be posting throughout the week.

Pharmacists can play an important role in educating patients about hand hygiene measures during COVID-19.

Patients treated with remdesivir achieved a median time to recovery of 10 days with remdesivir, compared with 15 days on the placebo.

October marks American Pharmacists Month, and on October 12, we celebrate Women Pharmacist Day.

The next thoughtful proposal in which pharmacy technicians can assist with mitigating COVID-19 infections is the administration of a vaccine in the community pharmacy settings.

To celebrate American Pharmacists Month, Pharmacy Times spoke with several pharmacists about their experiences during the COVID-19 pandemic and how they have tackled its unique challenges.

Report recommends using existing systems across all levels of government to provide necessary resources to ensure equitable allocation, distribution, and administration of the COVID-19 vaccine.

With 35% of Americans saying they do not trust the speed at which clinical trials are progressing, education and transparency are essential to increasing public trust in a COVID-19 vaccine.

This webcast discusses a number of topics pertaining to the substance use epidemic and updates in the use of naloxone especially during the COVID-19 pandemic.

Pharmacy Times® interviewed Nancy Lyons, BSPharm, MBA, CDE, vice president and chief pharmacy officer for Health Mart, and Pete Slone, senior vice president of public affairs for McKesson, on the importance of payment models that reward pharmacists’ commitment to patient services.

During American Pharmacists Month, and as the country uses all available health care resources to address COVID-19, there has never been a better or more important time to grant provider status to pharmacists.